The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail info@hpra.ie


ACARIZAX 12 SQ-HDM oral lyophilisate



ALK-Abello A/SPA1255/010/001

Main Information

Trade NameACARIZAX 12 SQ-HDM oral lyophilisate
Active SubstancesDermatophagoides Farinae Extract
Dermatophagoides Pteronyssinus Extract
Dosage FormOral lyophilisate
Licence HolderALK-Abello A/S
Licence NumberPA1255/010/001

Group Information

ATC CodeV01AA03 house dust mites

Status

License statusAuthorised
Licence Issued29/11/2019
Legal statusProduct subject to prescription which may be renewed (B)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of LicenceMedicinal product subject to restricted medical prescription (see: Summary of Product Characteristics, section 4.2).
Marketing StatusUnknown

Documents

Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back